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Benign cysts are one of the most common mass-occupying lesions of the breast and are often investigated with triple diagnostic
trial (clinical examination, radiology, and cytology). Malignant melanoma is one of medicine’s imitators, and metastatic disease
can mimic cysts. Thorough investigation of any breast mass is essential to clarify its nature.
1.CaseReport
A 42-year-old woman presented with bilateral lesions of the
breasts which on ultrasound examination were considered
hypoechoic cyst-like lesions with sharply demarcated mar-
gins (Figure 1). FNAC (ﬁne needle aspiration cytology)
was performed as part of the triple test, and air-dried,
May-Gr¨ unwald-Giemsa-stained smears interpreted by the
cytopathologist on duty revealed dissociated mononuclear
cells of uncertain origin (Figure 2). Ductal and apocrine
epithelia were absent. Scattered cells had uncharacteristic
pigment with slightly enlarged nuclei. The cytopathologist
ordered a repeat FNAC for ancillary tests. Flow cytometry
was inconclusive without distinct populations, probably due
to low cellularity and fragile cells which were destroyed
during the staining procedure. Immunocytochemistry was
positive for Melan-A (Figure 3), negative for cytokeratin.
Final diagnosis was consistent with malignant melanoma,
probably metastases. The patient died 10 months later due
to widespread disease.
2. Discussion
FNAC is commonly used as part of the diagnostic triad,
which in addition includes clinical breast examination and
ultrasonography. The diagnostic accuracy is close to 100%
when all three modalities favour a benign or malignant diag-
nosis [1]. Metastases are rarely found in the breast. Vergier
et al. published that approximately 2% of breast tumours
are metastases [2]. In our hospital malignant melanoma is
the most common primary cancer for metastatic disease to
the breast [3]. Speciﬁc ultrasound description of metastatic
malignant melanoma in the breast is sparse, but the “cyst-
like” hypoechogenic character with sharply demarcated mar-
gins has previously been reported [4, 5].
Thiscasedemonstratesthatnotallcyst-likebreastlesions
are benign, and morphologic examination of cyst content
by experienced cytopathologist may contribute to ﬁnal diag-
nosis or change of further diagnostic approach.
Unknown to the investigators she had, ﬁve months prior
to the breast investigation, underwent a neck dissection with
superﬁcial parotidectomy, and histological examination of
the specimen showed metastasis from malignant melanoma.
In search for primary focus, skin examination by dermatol-
ogist was negative, but a PET scan showed unspeciﬁc uptake
in one breast, and she was admitted to the breast centre.
Median survival after diagnosis of breast metastases from
malignant melanoma is 12,9 months [4]. Surgery is the
choice of treatment in absence of other metastases [6].
Malignant melanoma metastasis in the breast usually occurs
in advanced-stage disease and the beneﬁt of early detection is










Figure 1: Hypoechoic lesion with demarcated margins and weak
echo enhancement.
Figure 2:Smeardominatedbylargemononuclearcellswithslightly
condensed basophilic cytoplasm and enlarged nucleoli.
Figure 3: Mononuclear cells positive for Melan-A, consistent with
metastatic cells.
For adequate treatment, independent of prognosis, any
malignancy should be classiﬁed to the correct stadium. It is
therefore essential for the radiologist and pathologist to be
aware of the pitfalls in diagnostics.
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